NANOVIRICIDES, INC. Investment Income, Interest
NANOVIRICIDES, INC. (NNVC) reported Investment Income, Interest of $8.82 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2015-11-09
- NANOVIRICIDES, INC. investment income, interest for the quarter ending 2015-09-30 was $8.82K, a 77.56% decline year-over-year.
- NANOVIRICIDES, INC. investment income, interest for the quarter ending 2015-06-30 was $4.82K, a 94.77% decline year-over-year.
- NANOVIRICIDES, INC. investment income, interest for the quarter ending 2015-03-31 was $35.01K, a 36.10% decline year-over-year.
- NANOVIRICIDES, INC. investment income, interest for the quarter ending 2014-12-31 was $81.70K, a 463.42% increase year-over-year.
- NANOVIRICIDES, INC. investment income, interest for fiscal 2015 was $160.86K, a 5.93% decline from fiscal 2014.
- NANOVIRICIDES, INC. investment income, interest for fiscal 2014 was $171.00K, a 207.63% increase from fiscal 2013.
- NANOVIRICIDES, INC. investment income, interest for fiscal 2013 was $55.59K, a 18.81% increase from fiscal 2012.
- NANOVIRICIDES, INC. investment income, interest for fiscal 2012 was $46.79K, a 226.29% increase from fiscal 2011.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 3 month as first filed | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month | Investment Income, Interest 77 month | Investment Income, Interest 80 month | Investment Income, Interest 83 month | Investment Income, Interest 86 month | Investment Income, Interest 89 month | Investment Income, Interest 92 month | Investment Income, Interest 95 month | Investment Income, Interest 99 month | Investment Income, Interest 101 month | Investment Income, Interest 104 month | Investment Income, Interest 107 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-09-30 | $8.82K 10-Q · filed 2015-11-09 | $13.65K derived: sum of 2 quarters · filed 2015-11-09 | $48.66K derived: sum of 3 quarters · filed 2015-11-09 | $130.36K derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||
| 2015-06-30 | $4.82K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $39.83K derived: sum of 2 quarters · filed 2015-09-14 | $121.53K derived: sum of 3 quarters · filed 2015-09-14 | $160.86K 10-K · filed 2015-09-14 | ||||||||||||
| 2015-03-31 | $35.01K 10-Q · filed 2015-05-15 | $116.71K derived: sum of 2 quarters · filed 2015-05-15 | $156.03K 10-Q · filed 2015-05-15 | $248.19K derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||
| 2014-12-31 | $81.70K 10-Q · filed 2015-02-25 | $121.03K 10-Q · filed 2015-02-25 | $213.18K derived: sum of 3 quarters · filed 2015-11-09 | $267.96K derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||
| 2014-09-30 | $39.32K 10-Q · filed 2015-11-09 | $131.47K derived: sum of 2 quarters · filed 2015-11-09 | $186.26K derived: sum of 3 quarters · filed 2015-11-09 | $200.76K derived: sum of 4 quarters · filed 2015-11-09 | ||||||||||||
| 2014-06-30 | $92.15K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-14 | $146.94K derived: sum of 2 quarters · filed 2015-09-14 | $161.44K derived: sum of 3 quarters · filed 2015-09-14 | $171.00K 10-K · filed 2015-09-14 | ||||||||||||
| 2014-03-31 | $54.79K 10-Q · filed 2015-05-15 | $69.29K derived: sum of 2 quarters · filed 2015-05-15 | $78.85K 10-Q · filed 2015-05-15 | $905.26K derived: sum of 4 quarters · filed 2015-09-14 | $346.55K 10-Q · filed 2014-05-15 | |||||||||||
| 2013-12-31 | $14.50K 10-Q · filed 2015-02-25 | $24.06K 10-Q · filed 2015-02-25 | $850.47K derived: sum of 3 quarters · filed 2015-09-14 | $850.47K derived: sum of 4 quarters · filed 2015-09-14 | $291.76K 10-Q · filed 2014-02-14 | |||||||||||
| 2013-09-30 | $9.56K 10-Q/A · filed 2015-02-23 | $835.97K derived: sum of 2 quarters · filed 2015-09-14 | $835.97K derived: sum of 3 quarters · filed 2015-09-14 | $851.47K derived: sum of 4 quarters · filed 2015-09-14 | $277.26K 10-Q/A · filed 2013-11-18 | |||||||||||
| 2013-06-30 | $826.41K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-09-14 | $826.41K derived: sum of 2 quarters · filed 2015-09-14 | $841.91K derived: sum of 3 quarters · filed 2015-09-14 | $55.59K 10-K · filed 2015-09-14 | $267.70K 10-K/A · filed 2013-10-08 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-15 | -$822.28K 10-Q/A · filed 2013-05-20 | $15.49K derived: sum of 2 quarters · filed 2014-05-15 | -$770.83K 10-Q/A · filed 2013-05-20 | $55.30K derived: sum of 4 quarters · filed 2015-02-23 | -$558.71K 10-Q/A · filed 2013-05-20 | ||||||||||
| 2012-12-31 | $15.49K 10-Q · filed 2014-02-14 | $51.45K 10-Q · filed 2014-02-14 | $55.30K derived: sum of 3 quarters · filed 2015-02-23 | $86.10K derived: sum of 4 quarters · filed 2015-02-23 | $263.56K 10-Q/A · filed 2013-02-22 | |||||||||||
| 2012-09-30 | $33.30K 10-Q/A · filed 2013-11-18 | $39.81K derived: sum of 2 quarters · filed 2015-02-23 | $70.61K derived: sum of 3 quarters · filed 2015-02-23 | $90.96K derived: sum of 4 quarters · filed 2015-02-23 | $245.41K 10-Q · filed 2012-11-19 | |||||||||||
| 2012-06-30 | $6.50K derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-02-23 | $37.30K derived: sum of 2 quarters · filed 2015-02-23 | $57.66K derived: sum of 3 quarters · filed 2015-02-23 | $46.79K 10-K · filed 2015-02-23 | $212.11K 10-K/A · filed 2012-10-26 | |||||||||||
| 2012-03-31 | $30.80K 10-Q/A · filed 2013-05-20 | $51.16K derived: sum of 2 quarters · filed 2013-05-20 | $40.28K 10-Q/A · filed 2013-05-20 | $67.83K derived: sum of 4 quarters · filed 2013-05-20 | $205.61K 10-Q · filed 2012-05-21 | |||||||||||
| 2011-12-31 | $20.36K 10-Q/A · filed 2013-02-22 | $9.48K 10-Q/A · filed 2013-02-22 | $37.03K derived: sum of 3 quarters · filed 2013-02-22 | $37.91K derived: sum of 4 quarters · filed 2013-02-22 | $174.81K 10-Q · filed 2012-02-14 | |||||||||||
| 2011-09-30 | $8.90K 10-Q · filed 2012-11-19 | $16.67K derived: sum of 2 quarters · filed 2012-11-19 | $17.55K derived: sum of 3 quarters · filed 2012-11-19 | $21.25K derived: sum of 4 quarters · filed 2012-11-19 | -$174.23K 10-Q/A · filed 2011-12-12 | |||||||||||
| 2011-06-30 | $7.77K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-10-26 | $8.65K derived: sum of 2 quarters · filed 2012-10-26 | $12.35K derived: sum of 3 quarters · filed 2012-10-26 | $14.34K 10-K/A · filed 2012-10-26 | ||||||||||||
| 2011-03-31 | $882.00 10-Q · filed 2012-05-21 | $4.58K derived: sum of 2 quarters · filed 2012-05-21 | $6.57K 10-Q · filed 2012-05-21 | |||||||||||||
| 2010-12-31 | $3.70K 10-Q · filed 2012-02-14 | $5.69K 10-Q · filed 2012-02-14 | ||||||||||||||
| 2010-09-30 | $1.99K 10-Q/A · filed 2011-12-12 | |||||||||||||||
| 2010-06-30 | $2.98K 10-K/A · filed 2012-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |